Hi there,

If you think Democracy Now!’s reporting is a critical line of defense against war, climate catastrophe and authoritarianism, please make your donation of $10 or more right now. Today, a generous donor will DOUBLE your donation, which means it’ll go 2x as far to support our independent journalism. Democracy Now! is funded by you, and that’s why we’re counting on your donation to keep us going strong. Please give today. Every dollar makes a difference—in fact, gets doubled! Thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


WTO to Start Negotiations on COVID Vaccine Patent Waivers, 8 Months After They Were Proposed

HeadlineJun 10, 2021

World Trade Organization members have agreed to begin negotiations next week on a temporary waiver of intellectual property rights for coronavirus vaccines. South Africa and India first proposed the patent waivers in October of 2020 as part of an urgent effort to increase the availability of vaccines in poorer countries. The effort has languished for more than eight months amid opposition from pharmaceutical companies and wealthy WTO members. Since then, the world has recorded over 2.6 million COVID deaths and 140 million new infections. On Wednesday, Argentine President Alberto Fernández and Spanish Prime Minister Pedro Sánchez said in a joint news conference that they support a waiver for COVID vaccine patents. This is Prime Minister Sánchez.

Prime Minister Pedro Sánchez: “Argentina and Spain are defending the liberation of vaccines, making them a global public good and, consequently, speeding up their distribution and increasing their production capacity for the whole of humanity to vaccinate all of our societies as quickly as possible and overcome this calamity that COVID-19 represents.”

The Biden administration initially opposed patent waivers for COVID vaccines, then reversed course in May amid intense pressure from advocacy groups and some Democrats. The European Union and several nations, including the U.K. and Switzerland, remain opposed.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation